SLC18A2 and Parkinson disease: In particular, VMAT2 radiotracer [11C]DTBZ and [18F]FP-DTBZ radioligands, are being successfully used for human PET studies of neurodegenerative, nigrostriatal DA deficit in Parkinson's disease (PD) and psychiatric diseases [53,54].